174 related articles for article (PubMed ID: 23631697)
1. Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles.
Nishikawa T; Takahashi T; Nakamori M; Yamazaki Y; Kurashige T; Nagano Y; Nishida Y; Izumi Y; Matsumoto M
Neuropathol Appl Neurobiol; 2014 Jun; 40(4):489-501. PubMed ID: 23631697
[TBL] [Abstract][Full Text] [Related]
2. The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments.
Nishikawa T; Takahashi T; Nakamori M; Hosomi N; Maruyama H; Miyazaki Y; Izumi Y; Matsumoto M
Neuropathol Appl Neurobiol; 2016 Dec; 42(7):639-653. PubMed ID: 26501932
[TBL] [Abstract][Full Text] [Related]
3. The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer's disease.
Hondius DC; Koopmans F; Leistner C; Pita-Illobre D; Peferoen-Baert RM; Marbus F; Paliukhovich I; Li KW; Rozemuller AJM; Hoozemans JJM; Smit AB
Acta Neuropathol; 2021 Mar; 141(3):341-358. PubMed ID: 33492460
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers for granulovacuolar degeneration are present in rimmed vacuoles.
Nakamori M; Takahashi T; Nishikawa T; Yamazaki Y; Kurashige T; Maruyama H; Arihiro K; Matsumoto M
PLoS One; 2013; 8(11):e80995. PubMed ID: 24312256
[TBL] [Abstract][Full Text] [Related]
5. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of flotillin-1 in tangle-bearing neurones of Alzheimer's disease.
Girardot N; Allinquant B; Langui D; Laquerrière A; Dubois B; Hauw JJ; Duyckaerts C
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):451-61. PubMed ID: 14507337
[TBL] [Abstract][Full Text] [Related]
7. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
Lagalwar S; Berry RW; Binder LI
Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology.
Andrés-Benito P; Carmona M; Pirla MJ; Torrejón-Escribano B; Del Rio JA; Ferrer I
Neuroscience; 2023 May; 518():119-140. PubMed ID: 34757172
[TBL] [Abstract][Full Text] [Related]
9. Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B).
Midani-Kurçak JS; Dinekov M; Puladi B; Arzberger T; Köhler C
Brain Res; 2019 Mar; 1706():224-236. PubMed ID: 30414727
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical examination of phosphorylated tau in granulovacuolar degeneration granules.
Ikegami K; Kimura T; Katsuragi S; Ono T; Yamamoto H; Miyamoto E; Miyakawa T
Psychiatry Clin Neurosci; 1996 Jun; 50(3):137-40. PubMed ID: 9201760
[TBL] [Abstract][Full Text] [Related]
11. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated NF-κB subunit p65 aggregates in granulovacuolar degeneration and neurites in neurodegenerative diseases with tauopathy.
Yamaguchi Y; Ayaki T; Li F; Tsujimura A; Kamada M; Ito H; Maki T; Sawamoto N; Urushitani M; Takahashi R
Neurosci Lett; 2019 Jun; 704():229-235. PubMed ID: 30946927
[TBL] [Abstract][Full Text] [Related]
13. Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles.
Hunter S; Minett T; Polvikoski T; Mukaetova-Ladinska E; Brayne C;
Alzheimers Res Ther; 2015 Aug; 7(1):57. PubMed ID: 26315613
[TBL] [Abstract][Full Text] [Related]
14. The origins of rimmed vacuoles and granulovacuolar degeneration bodies are associated with the Wnt signaling pathway.
Murata-Shinozaki Y; Takahashi T; Matsubara T; Maruyama H; Izumi Y; Matsumoto M
Neurosci Lett; 2017 Jan; 638():55-59. PubMed ID: 27939356
[TBL] [Abstract][Full Text] [Related]
15. Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles.
Funk KE; Mrak RE; Kuret J
Neuropathol Appl Neurobiol; 2011 Apr; 37(3):295-306. PubMed ID: 20946470
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration.
Nakamori M; Takahashi T; Yamazaki Y; Kurashige T; Yamawaki T; Matsumoto M
Neuroreport; 2012 Oct; 23(15):867-72. PubMed ID: 22968343
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.
García-Sierra F; Wischik CM; Harrington CR; Luna-Muñoz J; Mena R
J Chem Neuroanat; 2001 Jul; 22(1-2):65-77. PubMed ID: 11470555
[TBL] [Abstract][Full Text] [Related]
18. New patterns of intraneuronal accumulation of the microtubular binding domain of tau in granulovacuolar degeneration.
Mena R; Robitaille Y; Cuello AC
J Geriatr Psychiatry Neurol; 1992; 5(3):132-41. PubMed ID: 1323297
[TBL] [Abstract][Full Text] [Related]
19. Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer's disease.
Koper MJ; Van Schoor E; Ospitalieri S; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Tousseyn T; Balusu S; De Strooper B; Thal DR
Acta Neuropathol; 2020 Mar; 139(3):463-484. PubMed ID: 31802237
[TBL] [Abstract][Full Text] [Related]
20. Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.
Bondareff W; Wischik CM; Novak M; Roth M
Am J Pathol; 1991 Sep; 139(3):641-7. PubMed ID: 1909492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
